CRYPTO:INJUSD

Injective Usd Cryptocurrency News

etoro logo Buy INJUSD
*Your capital is at risk
$4.85
-0.0800 (-1.62%)
At Close: Aug 04, 2026
Injective (INJ) shows bullish momentum with MACD histogram turning positive and RSI in neutral territory, targeting $6.20 within 4-6 weeks as analysts eye $5.80-$6.50 range.
Injective showing bullish MACD signals and neutral RSI positioning for potential recovery to $5.80-$6.50 range, with critical resistance at $5.42 determining next move.
INJ price prediction points to potential 25-50% upside to $5.80-$6.50 range as technical indicators show early bullish momentum despite current weakness at $4.32.
Injective faces critical support at $4.35 with bullish MACD signals suggesting potential 45-60% recovery to $6.50-$7.20 range within 4-6 weeks if key resistance breaks.
Injective's research page enhances transparency and accessibility, potentially fostering innovation and informed regulatory discussions in blockchain. Injective launches research page for seamless acc
INJ price prediction shows potential recovery to $5.20-5.80 range within 4-6 weeks as MACD histogram turns positive and RSI rebounds from oversold conditions.
INJ price prediction shows mixed signals with short-term bounce to $4.84 possible, but medium-term Injective forecast warns of $3.36 target amid bearish momentum.
INJ price prediction shows potential recovery to $4.84 within days, with medium-term Injective forecast targeting $7.50-$8.00 range as technical indicators signal bullish momentum.
INJ price prediction points to $4.84 target by December 26 as technical analysis reveals potential bounce from $4.72 support, though bearish momentum persists.
INJ price prediction suggests recovery to $4.84-$4.93 range within 30 days as technical indicators show oversold conditions near Bollinger Band support at $4.26.
INJ price prediction points to $4.84 recovery by December 26, despite current bearish momentum. Critical $4.72 support level holds the key for Injective's near-term direction.
TLDR: The technical amendment defines BitGo as custodian and U.S. Bancorp for cash management. The fund plans to delegate all its assets to staking providers to generate yields. INJ price faces a tech
Canary Capital has submitted an S-1 filing to the U.S. SEC for a staked Injective ETF that would list on Cboe.
Canary refiles S-1 for a staked Injective ETF, detailing custodians, staking plan, and Cboe BZX listing as INJ price and derivatives markets show mixed signals. Canary Capital has filed an amended S-1
Canary Capital has filed a revised S-1 registration statement with the US Securities and Exchange Commission (SEC) for its proposed staked INJ exchange-traded fund (ETF).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE